Mandate

Vinge advised Fortum Värme in connection with the Swedish Competition Authority’s three-year investigation regarding the price of district heating in Stockholm

November 15, 2010

Since October 2007 the Swedish Competition Authority has investigated whether Fortum Värme, jointly owned by Fortum and the City of Stockholm, abused a dominant position in breach of the Swedish Competition Act by imposing unfairly high prices (excessive pricing) on its district heating customers in the Stockholm area. The Competition Authority has, by its unconditional decision on 12 November 2010, now closed the extensive and detailed investigation without any further actions. Fortum Värme has, during the investigation, declared its intention to ensure, for 2011, that the revenues generated from its district heating operations in Stockholm do not exceed a revenue cap defined by the company.     

Vinge’s competition team included responsible partner Johan Karlsson and several associates, including Carl Johan Sundqvist and Emil Fahlén Godö. Part of the team was also associate professor Mattias Ganslandt who, inter alia, contributed with several economic reports concerning the market for district heating and Fortum Värme’s pricing.

The Swedish Competition Authority’s decision and press release

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025